Investigation and verification of GIMAP6 as a robust biomarker for prognosis and tumor immunity in lung adenocarcinoma.

Xiuqiong Chen,Zhaona Li,Xinyue Wang,Jing Zhou,Qianhui Wei,Kaidi Chen,Richeng Jiang

Journal of cancer research and clinical oncology（2023）

引用 0|浏览3

暂无评分

摘要

These findings confirmed that GIMAP6 was an effective prognostic molecule that was involved in the regulation of the immune microenvironment of LUAD, and may become a predictor for the efficacy of immunotherapy.

查看译文

关键词

GTPase of immunity-associated protein 6, Lung adenocarcinoma, Prognosis, Immunity, Immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要